共 50 条
Induced pluripotent stem cell therapies in heart failure treatment: a meta-analysis and systematic review
被引:0
|作者:
Le, Duy Cao Phuong
[1
,3
]
Bui, Hoa The
[1
]
Vu, Yen Thi Hai
[2
]
Vo, Quan Duy
[1
,3
,4
]
机构:
[1] Nguyen Tri Phuong Hosp, Dept Cardiovasc Intervent, Ho Chi Minh City 700000, Vietnam
[2] Thai Binh Univ Med, Fac Med, Thai Binh 61000, Vietnam
[3] Nguyen Tat Thanh Univ, Fac Med, Ho Chi Minh City 700000, Vietnam
[4] Okayama Univ, Cardiovasc Med Dept, Okayama 7000000, Japan
关键词:
heart failure;
induced pluripotent stem cells;
meta-analysis;
outcomes;
treatment;
ACUTE MYOCARDIAL-INFARCTION;
CARDIAC-MUSCLE;
REPAIR;
TRANSPLANTATION;
EFFICACY;
DIFFERENTIATION;
CARDIOMYOCYTES;
REGENERATION;
ENGRAFTMENT;
SKELETAL;
D O I:
10.1080/17460751.2024.2393558
中图分类号:
Q813 [细胞工程];
学科分类号:
摘要:
Background: Heart failure (HF) causes over 266,400 deaths annually. Despite treatment advancements, HF mortality remains high. Induced pluripotent stem cells (iPSCs) offer promising new options. This review assesses iPSC-based treatments for HF. Method: the review included studies from PubMed, ScienceDirect and Web of Science. Results: Analysis of 25 studies with 553 animals showed a baseline ejection fraction (EF) of 39.2 +/- 8.9%. iPSC treatment significantly improved EF (MD = 8.6, p < 0.001) and fractional shortening (MD = 6.38, p < 0.001), and reduced ventricular remodeling without increasing arrhythmia risk. Conclusion: iPSC-based therapy improves heart function and reduces ventricular volumes in HF animal models, aligning with promising early clinical trial outcomes.
引用
收藏
页码:497 / 509
页数:13
相关论文